Background: Heart failure (HF) is a major public health problem and represents the only cardiac disease continuing to increase in prevalence, in particular among elderly patients. The frequent rehospitalizations have a negative impact on quality of life of patients with HF, constituting a substantial cost for patients and the health system.
| INTRODUCTION
Heart failure (HF) is a chronic disabling cardiac condition which mainly involves people aged 65 and older, accounting for more than 75% of HF hospitalizations. 1 Elderly patients are more prone to experience diastolic HF (preserved systolic function) and often experience a series of adverse clinical outcomes, including hospitalizations, for acute decompensated HF (ADHF), 2 increased congestion, volume overload, 3 ischaemic heart disease (IHD) myocarditis and for noncardiovascular causes. Among these latter, comorbidity, pre-existing disability and frailty are key relevant determinants of prognosis. Frailty is a multidimensional state characterized by loss of physiological reserve, which accumulates in older adults and predicts adverse outcomes. 4 Both Fried frailty criteria 5 and the Rockwood cumulative frailty index 6 incorporate cardiovascular diseases and atherosclerosis as key relevant determinants of frailty trajectory. Noncardiac comorbidity is greatly overlooked in chronic HF (CHF) routine this fact, it is highly recommended to include elderly patients with HF in special follow-up programmes as an effective measure for reducing readmissions. In line with these assumptions, several models have been proposed for predicting postdischarge risk in HF patients. 12, 13 Few stratification models have been validated in emerging department (ED) to inform physician's clinical decision making process, showing effectiveness in identifying lower risk patients. 14 So far, the availability of validated prognostic indexes in older adults is still missing and it could be of key relevance in appropriate risk stratification, therapeutic degree of aggressiveness and/ or palliative discharge and quality of life. This narrative review is based on the material searched for and obtained via PubMed from January 2000 up to March 2018. The search terms we used were as follows: "elderly, heart failure, cardiovascular" in combination with "biomarker, echocardiography and hospitalization." As reported in the flow diagram ( Figure 1 ), 707 articles were initially found. Once identified the most recurrent predictors, the most relevant papers were then selected for each biomarker.
| BIOMARKER PREDICTORS

| Anaemia
In elderly patients with both HF and systolic dysfunction, anaemia is a powerful predictor of rehospitalization, morbidity and greater mortality. 15, 16 Patients with chronic HF taking part in the TIME-CHF study with a mean age of 77 ± 8 years were evaluated with respect to predictors of hospital readmission or death after 30 and 90 days of observation; in this setting, anaemia was an independent predictor of readmission or death at 30 days. 17 It has been demonstrated that in elderly patients with systolic HF and anaemia, subcutaneous erythropoietin leads to benefits in terms of increase in haemoglobin levels, improvement in NYHA functional class, reduction in hospitalization rates and diuretic requirements. [18] [19] [20] It is noteworthy, that even low normal haemoglobin levels may be a marker of functional impairment. A recent study of 1.146 communitydwelling elderly subjects has demonstrated that women with HF and low normal haemoglobin levels (12 to 13 g/ dL) performed worse than the counterparts with normal haemoglobin levels (13 to 15 g/dL) on walking and daily activities. 
| C-reactive protein
It is long-time known that C-reactive protein (CRP), particularly if assessed with high-sensitivity assays (hsCRP), is a strong independent predictor of risk of cardiovascular disease (acute myocardial infarction and stroke). 22 So far, there are no targeted studies on the elders, because of the fact that in these patients multimorbidity conditioning the CRP levels is often present (infections and inflammaging associated with chronic degenerative diseases), so causing the inability to assess these parameters as specific biomarker to predict a clinical outcome. Altay et al 23 studied the significance of CRP as a strong independent predictor of clinically significant depression in elderly patients with HF. Depression is a really important aspect in patient with HF because the rate of rehospitalization seems to be significantly higher in this setting of patients that are frequently older. Furthermore, pathophysiological mechanisms for depression and cardiac illness resemble each other, and a common pathway, represented first of all by inflammation and neurohormonal dysfunction, may be found between HF and depression. According to recent literature review, this is particularly true in men aged 75 and older. 24 The main studies on the field are summarized in Table 1 .
| Natriuretic peptides and troponins
Natriuretic peptides, and especially the N-terminal pro-Btype natriuretic peptide (NT-proBNP), are, to date, important parameters in the diagnosis of HF 37 and the best predictors of prognosis in HF patients. 38 Furthermore, serial measurements of NT-proBNP may be used to assess the biomarker response to HF therapy 39, 40 and to optimize the pharmacologic approach. Sánchez et al demonstrated that, in elderly patients, the NT-proBNP value was associated with short-term mortality independently of the presence of confounding factors, such as the severity of ADHF and renal dysfunction. 27 Furthermore, in elderly patients, Belagavi and co-workers 26 demonstrated a correlation between NT-proBNP and worsening LVEF in patients presenting to emergency department with dyspnoea. However, elevated values of NT-proBNP should be interpreted due to the fact that the determination of its levels does not seem to help clinics in the definition of dyspnoea in patients with other comorbidities such as COPD, pulmonary hypertension, renal dysfunction. Gaggin and co-workers tried to characterize NT-proBNP response or not response to therapy. 28 Failure to achieve NT-proBNP values ≤1000 pg/mL was strongly associated with adverse outcome. Nonresponder patients were more likely to be older, to have NYHA functional class III or IV symptoms and had more prevalent atrial fibrillation. So, a prediction of future NT-proBNP nonresponders seems to be possible, particularly in elderly patients, and this consideration may help clinicians in deciding the intensity of care strategies. Other important biomarker of myocardial injury is cardiac troponins. Cardiac troponins (cTn), especially if measured with high-sensitivity assays (hs-cTnT), are frequently found chronically circulating in a wide variety of acute and chronic, cardiac and noncardiac disease conditions, including acute HF and chronic symptomatic and asymptomatic left ventricular dysfunction. 41 Several studies showed an association of troponin increase with worse clinical outcome, [42] [43] [44] particularly for what regards hs-cTnT assay in older patients, so as a general recommendation, the Global Task Force HF section recommends measuring cTn in patients with CHF. 45 Furthermore, recent studies have confirmed Hyperuricaemia is an independent predictor of mortality in elderly patients with HFrEF undergoing domiciliary-based intervention (OR 1.50; P = 0.038).
(Continues) the predictive role of cTnI in elderly patients with ADHF. Increased cTnI at admission was associated with in-hospital mortality and appeared as a good prognostic indicator of adverse outcomes. 46 The main studies on the field are summarized in Table 1 .
| Hyponatraemia
Hyponatraemia is the most common electrolyte abnormality found in HF hospitalized patients. 47 Gheorghiade et al studied the relationship between admission serum sodium concentration and clinical outcomes in a large cohort of 48 612 elderly patients hospitalized for HF, derived from the OPTIMIZE-HF registry. 29 Patients with hyponatraemia had significantly higher rates of in-hospital and short-term mortality (follow-up performed at 60 and 90 days) and longer hospital stays; readmission rates were equally high in patients with or without hyponatraemia. The incidence and prognostic importance of hyponatraemia in stable elderly outpatients with HF has been less described. Balling and co-workers studied the prevalence and the importance of hyponatraemia as a prognostic factor in a large cohort of elderly HF outpatients (Danish HF Clinics Network). They demonstrated that hyponatraemia is a significant independent predictor of hospitalization and death in these patients. 30 Bavishi et al 31 demonstrated that hyponatraemia predicts mortality in elderly patients both with reduced (HFrEF) or preserved ejection fraction (HFpEF). Hyponatraemia was prevalent at a similar frequency (over 10%) in ambulatory patients with HFpEF and HFrEF and was an independent prognostic marker of mortality in all these subjects. In contrast, it was an independent predictor for hospitalization in patients with HFrEF but not in patients with HFpEF. This relationship was confirmed by a study related to a nurse-led domiciliary intervention for elderly HF patients. 34 The main studies on the field are summarized in Table 1 . The role of hyponatraemia as predictor of worse outcome in HF patients must be confirmed by further studies in the elderly population.
| Vitamin D and parathormone
Immobilization and antisocial behaviour of HF patients, which is especially more prominent when they are depressive and older, may lead to inadequate exposure to sunlight and hence vitamin D deficiency. 48 Low serum vitamin D levels, or more precisely inadequate biologic vitamin D activity, cause serum parathormone (PTH) excess namely secondary hyperparathyroidism (SHPT) which may contribute to the systemic illness that accompanies CHF. 49 However, the relationship between PTH levels with parameters of HF is rarely presented in the literature. 50 In an interesting study, Bozic et al demonstrated that in elderly vitamin D insufficient men, with mild to moderate CHF, PTH levels but not low vitamin D presented a close relationship with CHF severity and mortality. 33 Bozic's study also showed that the subgroup of CHF patients with vitamin D insufficiency but blunted PTH had less advanced HF and lower mortality compared with the group that had secondary hyperparathyroidism (SHPT). Recently, Sugimoto and co-workers in an interesting study 32 involving mainly elderly patients (age 69 ± 15 years) demonstrated that serum PTH levels ≥47 pg/ mL were optimal cut-off points for hospitalization for HF; thus, in patients with vitamin D insufficiency, serum PTH increase may be considered an important predictor of the severity of CHF. This study also showed that endothelial dysfunction was present in SHPT patients. Increased PTH, as a covariant of CHF, is known to provoke oxidative stress with a consequent, negative potential influence on vascular function. 51 Altay and co-workers investigated the association between depression and serum PTH levels in elderly patients with systolic HF. 23 They demonstrated that systolic HF patients who were depressed (moderate or severe degree) had higher serum levels of PTH and CRP, poor functional status and lower LVEF. The association between depression and such parameters might explain how depression affects hospitalization and mortality in HF. The main studies on the field are summarized in Table 1 .
Further investigation is needed to understand the potential interaction of depression, increased PTH and CRP in the pathophysiology of systolic HF, all of which may simply be markers or may drive causality. In the BIO-HF registry, renal dysfunction is associated with in-hospital and short-term mortality after discharge in patients admitted for AHF (P < 0.05) OR, odds ratio; CI, confidence interval; CV, cardiovascular; HR, hazard ratio; HF, heart failure; NT-proBNP, N-terminal prohormone of brain natriuretic peptide; AHF, acute heart failure; LVEF, left ventricular ejection fraction; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; PTH, parathyroid hormone.
| Parameters of renal function and hyperuricaemia
Renal dysfunction is often present and/or worsens in elderly patients with HF. In elderly HF patients, major determinants of renal dysfunction are age, prior history of hypertension, evidence of atherosclerotic coronary or peripheral artery disease, HF severity, lower diastolic blood pressure and intensity of diuretic treatment. 52, 53 A recent study about outcomes of elderly patients admitted with HF in Belgium (the BIO-HF registry) has demonstrated that reduced kidney function is present in the majority of patients. In-hospital and shortterm mortality after discharge remain high and are mainly related to the presence of this comorbidity. 36 Furthermore, renal dysfunction is associated with increased costs of care, complications and mortality, and presents greater prevalence in patients with more severe symptoms. 54 Hyperuricaemia, due to either renal function impairment or diuretic treatment, 35, 55 is associated with poor outcomes in patients with mild to severe HF. 35, 56, 57 The Japanese Cardiac Registry of HF in Cardiology (JCARE-CARD) prospectively studied the characteristics and treatments in a broad sample of hospitalized elderly HF patients. Outcomes were followed for 2.1 years, and hyperuricaemia was present in 56% of all patients in this cohort. 58 In a study by Hamaguchi and coworkers, 25 the data from the JCARE-CARD were analysed and demonstrated that hyperuricaemia was common in elderly patients hospitalized with worsening HF encountered in clinical practice and that higher serum UA was independently associated with long-term adverse outcomes in these patients, in particularly hyperuricaemia was a prognostic indicator for hospital readmission, especially in elderly patients with HF. In a study related to nurse-led domiciliary intervention for elderly HF patients, Rondinini and co-workers 34 confirmed the important role of hyperuricaemia as an independent predictor of mortality. Hyperuricaemia is also a common finding in patients with ADHF. As recently reported by Alimonda et al, 35 in a study mainly involving elderly subjects admitted with ADHF, hyperuricaemia is "more than a single spectator." In ADHF, hyperuricaemia is not only a long-term prognostic marker for death but is also a predictor for new HF readmissions. 59 The main studies on the field are summarized in Table 1 .
| ECHOCARDIOGRAPHIC PARAMETERS
It is known that echocardiographic parameters, such as chamber dimensions, LVEF, E/e' ratio and mitral inflow deceleration time, have prognostic value in predicting longterm rehospitalization and HF-related mortality. 60, 61 Some of these parameters have been shown to be better predictors of prognosis and longer-term readmission than clinical parameters, but systolic dysfunction, evaluating through LVEF, has been evaluated as the best prognostic factor. 60 In very older patients (80 years and older), left ventricular dysfunction is a predictor of poorer outcomes and repetitive hospitalizations. 62 Several authors showed the usefulness of the combined study of systolic function by LVEF and diastolic function by E/e' ratio to predict prognosis in patients with HF. 63, 64 A recent work by Thavendiranathan, 65 involving elderly patients admitted with ADHF and enrolled in a hospital-to-home transitional care programme, has shown that an E/e' cut-off of 23 identified a high risk for 30-day readmission. A previous work by Liang and coworkers 66 has demonstrated the prognostic role of left atrial volume index (LAVI). These data were confirmed by further studies. Among the echocardiographic variables, parameters of left ventricular diastolic dysfunction and LAVI were the most predictive of future HF events. 67 Furthermore, it has been demonstrated the prognostic importance of the measurement of right atrial pressure (RAP) estimation by hand-carried ultrasound (HCU) assessment of inferior vena cava (IVC) size and collapsibility. 68 The main advantage of this measurement may be the feasibility of IVC assessment, even for noncardiologists. 69, 70 Other echocardiographic parameters which may play a role for risk-stratifying patients with HF include the evaluation of right ventricular (RV) function and pulmonary pressures. 71 Unfortunately, in elderly patients, there are no sufficient data to confirm this relationship. Some authors have hypothesized that the prognostic power of echocardiographic parameters may be increased by combining them with natriuretic peptides testing. Indeed, Dini and coworkers 72 have demonstrated that the combination of Doppler assessment of E/e' ratio and plasma NT-proBNP testing is useful to better stratify patients with stable systolic HF, particularly in those with minor degrees of diastolic dysfunction. Furthermore, an interesting study by Carbone and co-workers 73 have confirmed the prognostic value of NT-proBNP and IVC diameters and collapsibility, as evaluated using an HCU in predicting early readmission in elderly HF patients, but also extended this predictive power up to 60 days. This finding is in partial agreement with the recent study by Pelliccori and co-workers, 68 involving elderly patients. Carbone et al showed that HCU assessment of IVC at both admission and discharge might be useful to better recognize subclinical volume overload (even better than natriuretic peptide) and predict rehospitalization for ADHF. However, to date, the role of echocardiography upon hospitalization in predicting 30-day HFspecific readmission risk appears unclear. Keenan and coworkers 11 have developed and validated a score to predict 30-day all-cause readmission in elderly patients admitted with HF. Unfortunately, this score does not use echo parameters other than LVEF in risk prediction, and the value of LVEF alone as a predictor of readmission has been inconsistent in this study. Another score for elderly patients admitted with HF has been introduced by Thavendiranathan. 65 This score uses a combination of 20
clinical, hemodynamic and pathology parameters along with LVEF to identify patients at the highest risk of readmission. The main studies on the field are summarized in Table 2 .
| GERIATRIC CLINICAL
PREDICTORS OF HOSPITALIZATION
The comprehensive geriatric assessment 74 represents the gold standard for predicting overall mortality, and major clinical outcomes in elders. However, it is of specialist expertise and time demanding, making it barely incorporated into routine clinical practice. In addition, this instrument may not adequately characterize frailty in patients with cardiac conditions. To fill this gap, Tsuchihashi et al validated a prognostic model, including comorbidity and socioeconomic factors in patients with HF, 75 addressing the inclusion of social frailty indicators, as marker of hospital readmission. Moreover, postdischarge patient formal and informal support is a strong predictor for CHF readmission.
The higher comorbidity, polypharmacy and the presence of cognitive dysfunction may greatly interfere with adherence to treatment, compliance, as well as with the progress of rehabilitation. 76 In older patients (80 years and more), nursing home residency is associated with unfavourable outcomes and repetitive hospitalizations. 62 Growing evidence has assessed the prognostication accuracy of disease-specific prognostic indexes to develop a precision model for driving decision-making process in cardiac failure. Heartspecific prognostic indexes have been developed to appropriately estimate patients' survivals and clinical outcomes. Namely, the cardiac HF (3C_HF score), based on physical performance, has been attributed to the highest prediction, overcoming the adult cardiac prognostic model based on traditional risk factors. 77 Additionally, the inclusion of frailty determinants into cardiac prognostic models has been progressively applied, showing that physical performance test, gait of speed and functional decline were the most reliable predictors. 78 Recently, a new integrated model has been developed, incorporating both 3C_HF score and gait speed analysis, showing that the incremental value of gait speed was able to accurately predict prognosis in older patients with HF. This model represents a step forward in the understanding of frailty trajectories in elderly, as gait speed represents one major determinant of Fried model of frailty. However, further studies are needed to accurately stratify interventions, outcomes and tailored informed decision-making. Frailty is a common geriatric syndrome, characterized by the decline of physiological systems and reserve with inadequate response to minimal environmental stressors, leading to higher clinical vulnerability. The role of frailty has been increasingly recognized in cardiovascular diseases, and it has been recently identified as an independent factor for long-term mortality and hospital readmission in nondependent older adults with heart failure. 79, 80 In line with that, the inclusion of a frailty indicator might improve the specificity of the available prognostic tools, providing more accurate patients' stratification. The frailty conceptual framework includes the Fried frailty phenotype model and the frailty index of Rockwood based on the progressive accumulation of deficit. Both types of assessment have been found to be associated with decreased hospitalization risk and improved overall mortality. In our opinion, in this context, the frailty model developed by Rockwood may better apply to the heterogeneity of the highly individualized frailty trajectory and it should somehow be integrated in patient's tailored prognostic assessment. However, these measures are not integrated in routine care for all patients since they are time-consuming and of specialist expertise. Thus, these assessments are often reserved for randomized controlled studies, as in the recent Systolic Blood Pressure Intervention Trial (SPRINT) or smaller target populations, such as among nursing home residents. To overcome this issue, the feasibility of identifying frailty indicators from clinical notes and linking these to clinically relevant outcomes has been investigated. The extracted frailty data correlated with mortality and/or hospitalizations at both the population and the individual levels, potentially serving as a proxy for the severity of frailty of the patient. Thus, the potential use of clinic notes could support opportunities for larger pragmatic studies of frailty with its incorporation into routine healthcare decision-making. So far, even if there is uncertainty on which frailty measurement best fits in with the cardio geriatric patient, a position paper from the AHA, American College of Cardiology and American Geriatrics Society states that future guidelines should consider the assessment of frailty domains as a reliable indicator of patient's biological age and health status. HFrEF and both high BNP levels and dilated IVC at discharge, resulted independent risk factors for hospital readmission. By contrast, the presence of low levels of sodium, high blood urea nitrogen and the absence of beta-blocker administration were associated with hospital readmission in patients with HFrEF. Furthermore, in patients with HFpEF, the absence of beta-blocker administration and depression were other risk factors for readmission, suggesting that different predictors accounted for HF readmission in patients with HFrEF and those with HFpEF. Several studies reported that anaemia is associated with poor outcomes in elders with HFpEF. 86, 87 Green et al 88 investigated the impact of erythropoietin in
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HFpEF, but no significant reduction in the rates of readmission to hospital was observed. In conclusion, HFpEF is more frequent in elders and associated with economic implications because of repetitive and prolonged hospitalizations, due to both cardiovascular and noncardiovascular causes. A recent study of Mavrea et al 89 showed that in HFpEF patients aged ≥65 years, the risk for HF aggravation and readmission to hospital was independently predicted by increased levels of BNP. Furthermore, the risk of noncardiovascular readmissions was predicted by increased levels of inflammatory biomarkers. Increased TNF-α levels predicted both cardiovascular and noncardiovascular readmissions, while increased levels of high-sensitivity C-reactive protein did not predict any of these outcomes. Currently, there are no decisive approaches for treating patients with HFpEF; therefore, preventing recurrences of HFpEF by managing the risk factors for readmissions is likely the best strategy. Eventually, therapeutic approaches specifically aimed to identify and treat depression, meticulous monitoring of BNP levels and assessment of IVC may help reducing readmission for HFpEF.
| CONCLUSIONS
Various biochemical, echocardiographic, demographic and socioeconomical parameters have predictive value in elderly HF patients, which constitute a class of high risk for readmission (Figure 2 ). The effort to systematically stratify the risk of future adverse outcome in elderly HF patients should be strongly considered in clinical practice to guide the follow-up, clinical decision making process, improving quality of care and quality of life for elderly patients. Noteworthy, several dozens of models have been shown to effectively predict adverse outcomes, with higher discriminatory ability for predicting death rather than hospitalization. 90 However, different studies widely differed for the clinical setting, populations and variable used for modelling. On this basis, the emerging paradigm for risk stratification is the need of tailored multidisciplinary interventions. This is particularly true for the oldest old (patients 85 years and older) who have a guarded prognosis. Nursing home residency, class IV NYHA, impaired LVEF and renal insufficiency, that are common features in the oldest old, are associated with the highest risk for early death and repetitive hospitalizations. So far, single disease prognostic models have failed to estimate treatment risk and clinical outcomes in such a highly vulnerable population. These calculators are inaccurate for older adults since they generally underestimate risk in frail patients. A comprehensive and interdisciplinary management of older patients with heart failure should, therefore, start from a frailty assessment. In addition, the monitoring of frailty over time, considering its potential reversible causes, should also be part of patient's routinely assessment, along with the specific clinical trajectory of the heart failure disease. Namely, clinical interventions targeted on sarcopenia, poor mobility and malnutrition may provide some degree of reversibility on frailty. This dynamic approach may also enable the tailoring of therapeutic aggressiveness and the shifting to the palliative care approach, especially in the advanced stages of heart failure. Eventually, this new conceptual framework could deliver more appropriate care models and pathways for cardio geriatric patients. Such improvements may help us translate from a disease-centred model to a patient-tailored approach, ensuring better quality of care, better allocation of resources and, above all, better quality of life for older patient. Finally, it should acknowledge the limitations of this review. Undoubtedly, the study selection is flawed, but in line with the scope of a narrative review. Similarly, we did not discuss all the potential predictors of rehospitalization. Rather, we focused on those with major interest for the specific subset of elderly patients. 
